InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by KIM DENNIS D, Directeur Médical. Officer active across 1 companies, notably CymaBay Therapeutics, Inc.. In total, 2 filings have been recorded. Total volume traded: €107k. The latest transaction was disclosed on 19 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€53,66520,000 shares@ €2.6832100.0% of flow
Common Stock
SEC:0001062993-22-001295·
Ideal exit: 16 Oct 2022 (T+270)
€53,66520,000 shares@ €2.683250.0% of flow
Common Stock
SEC:0001062993-22-001295:0·
Ideal exit: 16 Oct 2022 (T+270)
2 of 2 declarations
About KIM DENNIS D
Dennis D. Kim is the Chief Medical Officer of CymaBay Therapeutics, Inc. He is responsible for the medical direction and clinical strategies of the company. With expertise in clinical research, he plays a key role in developing innovative treatments for rare diseases.
